日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antitumor efficacy of intermittent low-dose erlotinib plus sulindac via MHC upregulation and remodeling of the immune cell niche.

间歇性低剂量厄洛替尼联合舒林酸通过上调 MHC 和重塑免疫细胞微环境发挥抗肿瘤疗效

Tripathi Chakrapani, Tovar Perez Jorge E, Kapoor Sabeeta, Muhsin Ahmed, Dashwood Wan Mohaiza, Demirhan Yunus, Demirhan Melek, Shapiro Alessandro, Mohammed Altaf, Sei Shizuko, Thompson Jacklyn, Zaheer Mahira, Sinha Krishna M, Brown Powel H, Savage Michelle I, Vilar Eduardo, Rajendran Praveen, Dashwood Roderick H

Erlotinib suppresses tumorigenesis in a mouse model of colitis-associated cancer.

厄洛替尼可抑制结肠炎相关癌症小鼠模型中的肿瘤发生

Liu Max, Zhong Xiaoying S, Krishnachaitanya Srikruthi S, Ou Rongliwen, Dashwood Roderick H, Powell Don W, Li Qingjie

Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors

组蛋白酰基密码在精准肿瘤学中的应用:来自饮食和代谢因素的机制性见解

Neja, Sultan; Dashwood, Wan Mohaiza; Dashwood, Roderick H; Rajendran, Praveen

A-Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer

表观遗传学阅读器:靶向癌症中的可变剪接和组蛋白修饰变异

Mohan, Nivedhitha; Dashwood, Roderick H; Rajendran, Praveen

Epigenetic regulation of major histocompatibility complexes in gastrointestinal malignancies and the potential for clinical interception

胃肠道恶性肿瘤中主要组织相容性复合体的表观遗传调控及其临床干预潜力

Tovar Perez, Jorge Enrique; Zhang, Shilan; Hodgeman, William; Kapoor, Sabeeta; Rajendran, Praveen; Kobayashi, Koichi S; Dashwood, Roderick H

Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)

在家族性腺瘤性息肉病(FAP)Apc突变模型中优化厄洛替尼联合舒林酸给药方案以预防肠癌

Ulusan, Ahmet M; Rajendran, Praveen; Dashwood, Wan Mohaiza; Yavuz, Omer F; Kapoor, Sabeeta; Gustafson, Trace A; Savage, Michelle I; Brown, Powel H; Sei, Shizuko; Mohammed, Altaf; Vilar, Eduardo; Dashwood, Roderick H

Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls

利用拦截分子拦截癌症:叶绿素的机制、临床前和人体转化研究

Dashwood, Roderick H

Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting

会议报告:癌症预防药物研发转化进展会议

Miller, Mark Steven; Allen, Peter J; Brown, Powel H; Chan, Andrew T; Clapper, Margie L; Dashwood, Roderick H; Demehri, Shadmehr; Disis, Mary L; DuBois, Raymond N; Glynn, Robert J; Kensler, Thomas W; Khan, Seema A; Johnson, Bryon D; Liby, Karen T; Lipkin, Steven M; Mallery, Susan R; Meuillet, Emmanuelle J; Roden, Richard B S; Schoen, Robert E; Sharp, Zelton D; Shirwan, Haval; Siegfried, Jill M; Rao, Chinthalapally V; You, Ming; Vilar, Eduardo; Szabo, Eva; Mohammed, Altaf

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report

癌症预防药物研发转化进展(TACPAD)免疫调节剂虚拟研讨会:报告

Mohammed, Altaf; Dashwood, Roderick H; Dickinson, Sally; Disis, Mary L; Jaffee, Elizabeth M; Johnson, Bryon D; Khleif, Samir N; Pollak, Michael N; Schlom, Jeffrey; Shoemaker, Robert H; Stanton, Sasha E; Wondrak, Georg T; You, Ming; Zhu, Hao; Miller, Mark Steven

Emerging crosstalk between long non-coding RNAs and Nrf2 signaling

长链非编码RNA与Nrf2信号通路之间正在出现相互作用

Bhattacharjee, Shamee; Li, Jia; Dashwood, Roderick H